TOI Historical PE Ratio image   This TOI PE ratio history page last updated 11/10/2022
TOI PE History Chart
PeriodPriceGAAPTTMPE
Q3 2022
11/9/2022
3.10-0.17-0.17NA
Q2 2022
8/9/2022
6.63-0.06NANA
Q1 2022
5/11/2022
5.620.21NANA
Q4 2021
3/10/2022
4.93-0.15NANA
TOI Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q3 2022
11/9/2022
3.10-0.17-0.68NA
Q2 2022
8/9/2022
6.63-0.06-0.24NA
Q1 2022
5/11/2022
5.620.210.846.7
Q4 2021
3/10/2022
4.93-0.15-0.60NA
Quotes delayed 20 minutes

Email EnvelopeFree TOI Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
The Oncology Institute (TOI) is categorized under the Miscellaneous sector; to help you further research PE history across stocks, below are some other companies in the same sector:

TRTN PE Ratio History
TSE PE Ratio History
UBP PE Ratio History
UPH PE Ratio History
URGN PE Ratio History
VCSA PE Ratio History
VLD PE Ratio History
VLTA PE Ratio History
VMD PE Ratio History
VORB PE Ratio History
On this page we presented the TOI PE Ratio History information for The Oncology Institute' stock. The average TOI PE ratio history based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 6.7. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average TOI PE ratio history based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this TOI PE ratio history result, against the recent PE: when this page was posted on 11/9/2022, the most recent closing price for TOI had been 3.10, and the most recent quarterly earnings result, annualized, was 0.84. Meanwhile, the most recent TTM earnings summed to NA. From these numbers, we calculate the recent TOI PE on 11/9/2022 based on annualized quarterly EPS was 3.7. Based on TOI's history, that recent PE is low relative to the historical average, with the recent PE 44.8% lower than the historical average PE across our data set for The Oncology Institute.

For self directed investors doing their due diligence on TOI or any other given stock, valuation analysis for TOI can greatly benefit from studying the past earnings and resulting PE ratio history calculations. This type of study can help inform an analysis as to whether the earnings trajectory over time and current versus historical average PE ratios justify the current stock market value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate The Oncology Institute PE ratio history — or the PE history for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for next earnings dates and also historical earnings surprises history for TOI. Thanks for visiting, and the next time you need to research TOI PE Ratio History or the PE ratio history for another stock, we hope our site will come to mind as your go-to PE ratio history research resource of choice.

Recommended: PFX market cap history, Institutional Holders of RESE, Top Ten Hedge Funds Holding USAG.

 

TOI PE Ratio History | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.